AMILORIDE

💡

Quick Summary

Amiloride is a potassium-sparing diuretic that directly blocks the epithelial sodium channel (ENaC) in the late distal convoluted tubule and collecting duct of the nephron. It is primarily used as an adjunct to thiazide or loop diuretics to prevent hypokalaemia in patients with hypertension or heart failure, and as the definitive targeted therapy for Liddle syndrome. Unlike aldosterone antagonists, its action is independent of aldosterone levels and it lacks steroid receptor affinity, making it uniquely useful when mineralocorticoid antagonists are ineffective or cause intolerable endocrine side effects.

🔬

Drug Identity

GENERIC NAMEAmiloride
MEDOBO IDMDBD0046
ATC CODEC03DB01
PHARMACOLOGICAL CLASSEpithelial Sodium Channel (ENaC) Blocker
THERAPEUTIC CLASSPotassium-Sparing Diuretic
THERAPEUTIC CATEGORYCardiovascular
CHEMICAL NAMEN-amidino-3,5-diamino-6-chloropyrazine-2-carboxamide hydrochloride
DRUG SOURCESynthetic
FDA APPROVAL1981
MODALITYSmall Molecule
DRUG TYPEstandard
MARKET STATUS● Approved
CORE USE TAGS
DiureticPotassium-SparingHypertensionHeart FailureENaC BlockerLiddle Syndrome
BRAND NAMES (GLOBAL)
MidamorModureticFrumilBurinex AKalurilAmilospareModuretAmiloride Hydrochloride
SYNONYMS
Amiloride HClAmiloride hydrochloride
📌

Indications & Uses

🎯 APPROVED INDICATIONS
  • Hypokalaemia — prevention and treatment in patients receiving potassium-wasting diuretics
  • Hypertension — as adjunctive therapy with thiazide or other kaliuretic diuretics
  • Congestive heart failure — as adjunctive therapy to maintain potassium balance
🔬 OFF-LABEL USES
  • Liddle syndrome — targeted therapy for this rare genetic hypertension caused by ENaC gain-of-function mutations
  • Lithium-induced nephrogenic diabetes insipidus — reduces polyuria by blocking lithium uptake via ENaC in the collecting duct
  • Cystic fibrosis — inhaled amiloride investigated to improve airway mucociliary clearance, though long-term clinical benefit remains unproven
MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current prescribing information, institutional protocols, and official clinical guidelines. Medobo is not responsible for clinical decisions made based on this content.